Morgan Stanley’s ERBA DIAGNOSTICS ERB Stock Holding History

Morgan Stanley’s Portfolio ERB Stock Details ERB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,125	Closed	-$3K	–	6644
2016 Q2	$3K	Hold	3,125	–	–	﹤0.01%	6341
2016 Q1	$3K	Hold	3,125	–	–	﹤0.01%	6381
2015 Q4	$4K	Buy	+3,125	New	+$5.21K	﹤0.01%	6436
2015 Q2	–	Sell	-1,000	Closed	-$4K	–	6879
2015 Q1	$4K	Hold	1,000	–	–	﹤0.01%	6380
2014 Q4	$3K	Hold	1,000	–	–	﹤0.01%	6417
2014 Q3	$4K	Sell	1,000 -1,000	-50%	-$2.84K	﹤0.01%	6379
2014 Q2	$4K	Hold	2,000	–	–	﹤0.01%	6329
2014 Q1	$5K	Hold	2,000	–	–	﹤0.01%	6257
2013 Q4	$5K	Buy	+2,000	New	+$3.8K	﹤0.01%	6165

Other funds holding ERB

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VIA

Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Morgan Stanley's ERB Position: Q3 2016 in Review

Morgan Stanley sold out of ERBA DIAGNOSTICS (ERB) in Q3 2016, closing a stake of 3,125 shares — an estimated $3K sold.

Morgan Stanley first reported a position in ERB in Q4 2013 and held it in 9 quarters. The position peaked at $5K in Q1 2014. 2 funds tracked by Wall St. Rank hold ERB as of Q3 2016.

Morgan Stanley reported no remaining ERBA DIAGNOSTICS position as of Q3 2016 after selling out during the quarter.
Morgan Stanley sold 3,125 ERBA DIAGNOSTICS shares in Q3 2016, an estimated $3K.
Morgan Stanley first reported a position in ERBA DIAGNOSTICS in Q4 2013 and held it in 9 quarters.
Morgan Stanley's ERBA DIAGNOSTICS position peaked at $5K in Q1 2014.
2 funds tracked by Wall St. Rank held ERBA DIAGNOSTICS as of Q3 2016.

Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.